Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Monobenzone 10% in Aqueous cream
131500000AABTBT
|
Generic compound preparation BNF 1315000 | Other miscellaneous topical preparations | Skin | 1 |
|
Nystan 100,000units/g cream
1310020U0BDAAAA
|
Nystan (Topical) | Nystatin | Skin | 1 |
|
Phenol liquefied
1311050P0AAABAB
|
Phenol liquefied (Topical) | Liquefied phenol | Skin | 1 |
|
Podophyllin paint
1307000J0AAABAB
|
Podophyllum | Podophyllum resin | Skin | 1 |
|
Polyfax ointment
1310011W0BCAAAB
|
Polyfax (Topical) | Polymyxins | Skin | 1 |
|
Polytar AF liquid
1309000C0BHACAU
|
Polytar (Scalp) | Coal tar | Skin | 1 |
|
Potassium permanganate 0.01% topical solution
1311060Q0AAALAL
|
Potassium permanganate | Potassium permanganate | Skin | 1 |
|
Propylene glycol 40% in Clobetasol 0.05% ointment
1304000G0AADBDB
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Purified talc powder
1302030T0AAAAAA
|
Talc | Talc purified | Skin | 1 |
|
Quinoderm 10 cream
1306010C0BQAAAT
|
Quinoderm | Benzoyl peroxide | Skin | 1 |
|
Regaine for Women Regular Strength 2% solution
1309000H0BBADAA
|
Regaine | Minoxidil | Skin | 1 |
|
Riemann P20 Once a Day sunfilter lotion SPF 30
130801000BBNZA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 1 |
|
Riemann P20 spray SPF 30
130801000BBPWA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 1 |
|
Ritlecitinib 50mg capsules
1309000Y0AAAAAA
|
Ritlecitinib | Ritlecitinib | Skin | 1 |
|
Salicylic acid 11% / Lactic acid 4% gel
1307000M0AAAXAX
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 1 |
|
Salicylic acid 12.5% / Camphor 3.11% liquid
1307000M0AABLBL
|
Salicylic acid (Warts/Calluses) | Salicylic acid | Skin | 1 |
|
Salicylic acid 2% / Sulfur 2% in Generic Unguentum M cream
1306010T0AABKBK
|
Sulfur (Topical) | Sulfur | Skin | 1 |
|
Salicylic acid 2% / Sulfur 2% in Hydrocortisone 1% cream
1304000V0AAEPEP
|
Hydrocortisone (Topical) | Hydrocortisone | Skin | 1 |
|
Salicylic acid 3% / Sulfur 3% in Emulsifying ointment
1306010T0AAASAS
|
Sulfur (Topical) | Sulfur | Skin | 1 |
|
Salicylic acid 3% in Aqueous cream
1305020S0AABTBT
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Salicylic acid 40% in Yellow soft paraffin
1305020S0AABUBU
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Salicylic acid 5% in Aqueous cream
1305020S0AADTDT
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Salicylic acid 5% in Clobetasol 0.05% cream
1304000G0AADCDC
|
Clobetasol propionate | Clobetasol propionate | Skin | 1 |
|
Salicylic acid 50% in Emulsifying ointment
1305020S0AADPDP
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 1 |
|
Savlon antiseptic liquid
1311020L0BSAHA2
|
Savlon (Topical Disinfectant) | Chlorhexidine gluconate | Skin | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.